Regular cannabis users consume once under supervision with saliva samples taken
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Anamnestically healthy, adult, cannabis-accustomed (i.e. cannabis use at least once a month) women and men of all ages and constitutional types. Regular cannabis use can be expressly accepted.
Exclusion criteria
Exclusion criteria: - Minors - Pre-existing cardiac and/or psychiatric conditions* - Pregnancy or breastfeeding* - First-time cannabis users* - Desired consumption of >500 mg cannabis per joint under study conditions - noticeable substance influence due to the consumption of (other) drugs/medication/alcohol on the day of the trial - Multiple use of cannabis during the study day *With regard to cannabis experience/pre-existing conditions/pregnancy, the selection procedure is based on the subjects' self-reporting, as the completely anonymous study design means that no personal/clinical anamnesis can be collected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to test whether the technical sensor DrugAsens® is able to deliver fully quantitative and valid results for the detection of Delta9-THC in saliva on the basis of its novel technology. The test system is expected to demonstrate high selectivity and agreement of its quantitative results in comparison to the forensically validated (chromatographic) reference method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proof of the validity of the pre-test results is a prerequisite for further developments/tests towards the routine suitability of the DrugAsens® (e.g. handling by trained laypersons etc.). | — |
Countries
Germany
Contacts
Universitätsklinikum Essen, Institut für Rechtsmedizin